UDI: Value Beyond Compliance

By AHRMM

In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.

Related Resources

Toolkits/Methodology
IV Strategies for Disruptions - How to Guide
How-to guide to managing IV disruptions.
Advisory
CMS Releases Proposed Rule for Hospital Value-Based Purchasing Program
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
Guides/Reports
Supply Chain Services Professional's Role in Achieving the Institute of Medicine's Six Aims for Improvement
In 2001 the Institute of Medicine (IOM) published
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Letter/Comment
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
On November 21, 2013, AHRMM submitted electronically
Guides/Reports
Crossing the Quality Chasm: A New Health System for the 21st Century